Kiri Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 28, 2025, 8:52 pm

Quick Insight

Kiri Industries Ltd, a player in the dyes and pigments industry, currently trades at 16.0 P/E with a market cap of 2,918 Cr., reflecting investor sentiment. Despite a modest ROE of 8.74% and a meager ROCE of 0.45%, the company faces challenges with a negative OPM of -8%. With a low P/BV ratio of 0.55x and a concerning ICR of -0.15x, the company's financial health raises red flags. Furthermore, high borrowings of ₹1,124 Cr. and a short CCC of 11 days indicate liquidity pressure. Investors should approach this stock with caution due to its weak operational performance and unsustainable financial leverage.

Competitors of Kiri Industries Ltd

All Competitor Stocks of Kiri Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:05 am

Below is a detailed analysis of the quarterly data for Kiri Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 202.00 Cr.. The value appears to be declining and may need further review. It has decreased from 205.00 Cr. (Mar 2025) to 202.00 Cr., marking a decrease of 3.00 Cr..
• For Expenses, as of Jun 2025, the value is 218.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 210.00 Cr. (Mar 2025) to 218.00 Cr., marking an increase of 8.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -16.00 Cr.. The value appears to be declining and may need further review. It has decreased from -5.00 Cr. (Mar 2025) to -16.00 Cr., marking a decrease of 11.00 Cr..
• For OPM %, as of Jun 2025, the value is -8.00%. The value appears to be declining and may need further review. It has decreased from -2.00% (Mar 2025) to -8.00%, marking a decrease of 6.00%.
• For Other Income, as of Jun 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 35.00 Cr., marking an increase of 29.00 Cr..
• For Interest, as of Jun 2025, the value is 60.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 54.00 Cr. (Mar 2025) to 60.00 Cr., marking an increase of 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -53.00 Cr.. The value appears strong and on an upward trend. It has increased from -64.00 Cr. (Mar 2025) to -53.00 Cr., marking an increase of 11.00 Cr..
• For Tax %, as of Jun 2025, the value is -2.00%. The value appears to be improving (decreasing) as expected. It has decreased from 0.00% (Mar 2025) to -2.00%, marking a decrease of 2.00%.
• For Net Profit, as of Jun 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from -85.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 95.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.82. The value appears strong and on an upward trend. It has increased from -15.22 (Mar 2025) to 1.82, marking an increase of 17.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:00 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:50 am

Below is a detailed analysis of the balance sheet data for Kiri Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2024) to 56.00 Cr., marking an increase of 4.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,191.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,760.00 Cr. (Mar 2024) to 3,191.00 Cr., marking an increase of 431.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,124.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 122.00 Cr. (Mar 2024) to 1,124.00 Cr., marking an increase of 1,002.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 355.00 Cr.. The value appears to be improving (decreasing). It has decreased from 478.00 Cr. (Mar 2024) to 355.00 Cr., marking a decrease of 123.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 4,725.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,411.00 Cr. (Mar 2024) to 4,725.00 Cr., marking an increase of 1,314.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 806.00 Cr.. The value appears strong and on an upward trend. It has increased from 470.00 Cr. (Mar 2024) to 806.00 Cr., marking an increase of 336.00 Cr..
• For CWIP, as of Mar 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Mar 2024) to 63.00 Cr., marking a decrease of 10.00 Cr..
• For Investments, as of Mar 2025, the value is 3,152.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,213.00 Cr. (Mar 2024) to 3,152.00 Cr., marking an increase of 939.00 Cr..
• For Other Assets, as of Mar 2025, the value is 705.00 Cr.. The value appears strong and on an upward trend. It has increased from 655.00 Cr. (Mar 2024) to 705.00 Cr., marking an increase of 50.00 Cr..
• For Total Assets, as of Mar 2025, the value is 4,725.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,411.00 Cr. (Mar 2024) to 4,725.00 Cr., marking an increase of 1,314.00 Cr..

Notably, the Reserves (3,191.00 Cr.) exceed the Borrowings (1,124.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Kiri Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 25.55. This value is within the healthy range. It has increased from 20.67 (Mar 23) to 25.55, marking an increase of 4.88.
• For Diluted EPS (Rs.), as of Mar 24, the value is 25.55. This value is within the healthy range. It has increased from 20.67 (Mar 23) to 25.55, marking an increase of 4.88.
• For Cash EPS (Rs.), as of Mar 24, the value is -7.57. This value is below the healthy minimum of 3. It has increased from -10.82 (Mar 23) to -7.57, marking an increase of 3.25.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 542.45. It has increased from 516.89 (Mar 23) to 542.45, marking an increase of 25.56.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 542.45. It has increased from 516.89 (Mar 23) to 542.45, marking an increase of 25.56.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 183.12. It has increased from 182.32 (Mar 23) to 183.12, marking an increase of 0.80.
• For PBDIT / Share (Rs.), as of Mar 24, the value is -0.67. This value is below the healthy minimum of 2. It has increased from -6.59 (Mar 23) to -0.67, marking an increase of 5.92.
• For PBIT / Share (Rs.), as of Mar 24, the value is -10.05. This value is below the healthy minimum of 0. It has increased from -16.02 (Mar 23) to -10.05, marking an increase of 5.97.
• For PBT / Share (Rs.), as of Mar 24, the value is -14.46. This value is below the healthy minimum of 0. It has increased from -17.23 (Mar 23) to -14.46, marking an increase of 2.77.
• For Net Profit / Share (Rs.), as of Mar 24, the value is -16.96. This value is below the healthy minimum of 2. It has increased from -20.25 (Mar 23) to -16.96, marking an increase of 3.29.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 25.66. This value is within the healthy range. It has increased from 20.58 (Mar 23) to 25.66, marking an increase of 5.08.
• For PBDIT Margin (%), as of Mar 24, the value is -0.36. This value is below the healthy minimum of 10. It has increased from -3.61 (Mar 23) to -0.36, marking an increase of 3.25.
• For PBIT Margin (%), as of Mar 24, the value is -5.49. This value is below the healthy minimum of 10. It has increased from -8.78 (Mar 23) to -5.49, marking an increase of 3.29.
• For PBT Margin (%), as of Mar 24, the value is -7.89. This value is below the healthy minimum of 10. It has increased from -9.45 (Mar 23) to -7.89, marking an increase of 1.56.
• For Net Profit Margin (%), as of Mar 24, the value is -9.25. This value is below the healthy minimum of 5. It has increased from -11.10 (Mar 23) to -9.25, marking an increase of 1.85.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 14.01. This value is within the healthy range. It has increased from 11.28 (Mar 23) to 14.01, marking an increase of 2.73.
• For Return on Networth / Equity (%), as of Mar 24, the value is 4.73. This value is below the healthy minimum of 15. It has increased from 3.98 (Mar 23) to 4.73, marking an increase of 0.75.
• For Return on Capital Employeed (%), as of Mar 24, the value is -1.83. This value is below the healthy minimum of 10. It has increased from -3.04 (Mar 23) to -1.83, marking an increase of 1.21.
• For Return On Assets (%), as of Mar 24, the value is 3.89. This value is below the healthy minimum of 5. It has increased from 3.33 (Mar 23) to 3.89, marking an increase of 0.56.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.04. This value is within the healthy range. It has increased from 0.01 (Mar 23) to 0.04, marking an increase of 0.03.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.28. It has decreased from 0.30 (Mar 23) to 0.28, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 24, the value is 0.98. This value is below the healthy minimum of 1.5. It has decreased from 1.13 (Mar 23) to 0.98, marking a decrease of 0.15.
• For Quick Ratio (X), as of Mar 24, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 23) to 0.62, marking a decrease of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.04. This value is below the healthy minimum of 4. It has increased from 2.75 (Mar 23) to 3.04, marking an increase of 0.29.
• For Interest Coverage Ratio (X), as of Mar 24, the value is -0.15. This value is below the healthy minimum of 3. It has increased from -5.41 (Mar 23) to -0.15, marking an increase of 5.26.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -2.85. This value is below the healthy minimum of 3. It has increased from -15.63 (Mar 23) to -2.85, marking an increase of 12.78.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,599.98. It has increased from 1,416.91 (Mar 23) to 1,599.98, marking an increase of 183.07.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.69. This value is within the healthy range. It has increased from 1.50 (Mar 23) to 1.69, marking an increase of 0.19.
• For EV / EBITDA (X), as of Mar 24, the value is -460.34. This value is below the healthy minimum of 5. It has decreased from -41.50 (Mar 23) to -460.34, marking a decrease of 418.84.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.66. This value is within the healthy range. It has increased from 1.56 (Mar 23) to 1.66, marking an increase of 0.10.
• For Price / BV (X), as of Mar 24, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 23) to 0.55, marking an increase of 0.01.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.66. This value is within the healthy range. It has increased from 1.56 (Mar 23) to 1.66, marking an increase of 0.10.
• For EarningsYield, as of Mar 24, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 23) to 0.08, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness